Search Results 281-290 of 17573 for treatment resistant depression
ROCHESTER, Minn. — A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have ...
The FLAME Study is a 16-week clinical trial to study treatment with lamotrigine or fluoxetine in bipolar I, II and bipolar schizoaffective depressed adults. The ...
A Study to Test the Effectiveness and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects with Drug-resistant Epilepsy · Overview.
This procedure can greatly and rapidly improve severe symptoms of depression, mania, catatonia or other mental health conditions.
Another lab test can confirm the presence of TB bacteria. The results often take several weeks. A lab test also can tell if it's a drug-resistant form of the ...
A Study Of Acute Stimulation For The Modulation Of Epileptic Events With A Closed-Loop Brain Interchange System In Drug Resistant Epilepsy · Overview.
Mayo Clinic neurologists are participating in multicenter studies of: Gene therapy for the treatment of medication-refractory mesial temporal lobe epilepsy (TLE) ...
... treatment prognoses in people diagnosed with depression — the leading cause of medical disability worldwide. The system works by identifying patterns within ...
Antidepressants with a sedating effect. Sometimes prescription medicines used mainly to treat depression may ease insomnia when taken in lower doses. Although ...
≥ 20 years of age · Have not been under antidepressant therapy previously. · Receiving outpatient care for nonpsychotic major depressive disorder. · Scheduled to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!